Quent Capital »

Ocular Therapeutix shares owned by Quent Capital

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Quent Capital from 13F filings

Historical chart of Quent Capital investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Quent Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Quent Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4k 753 4.46
2023-09-30 $2.0k 645 3.14
2023-06-30 $2.1k 401 5.16
2022-12-31 $1.4k 490 2.81

More positions owned by Quent Capital

Vanguard Russell 1000 Growth Etf Etf (VONG)
Ishares Msci Eafe Growth Etf Etf (EFG)
Spdr Nuveen Bloomberg Short Term Municipal Bond Etf Etf (SHM)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Apple Stock (AAPL)
Ishares Msci Emerging Markets Etf Etf (EEM)
Ishares Gold Trust Etf (IAU)
Spdr Bloomberg Short Term International Treasury Bond Etf Etf (BWZ)
Microsoft Corp Stock (MSFT)
Ishares Global Reit Etf Etf (REET)
Ishares Msci Eafe Etf Etf (EFA)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Spdr Dow Jones Global Real Estate Etf Etf (RWO)
Spdr S&p 500 Etf Trust Etf (SPY)

View all positions for Quent Capital

Top funds holding Ocular Therapeutix

VR Adviser
Summer Road
Opaleye Management
Vanguard Group
Franklin Resources
Logos Global Management
Citadel Advisors
Deltec Asset Management
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Banco Santander
Artia Global Partners
D. E. Shaw & Co
Essex Investment Management
Bank of New York Mellon

View all funds holding Ocular Therapeutix